Heron Therapeutics Inc. buy Rodman & Renshaw
Start price
13.06.24
/
50%
€3.38
Target price
13.06.25
€6.48
Performance (%)
-51.39%
End price
14.06.25
€1.65
Summary
This prediction ended on 14.06.25 with a price of €1.65. The BUY prediction by Rodman___Renshaw for Heron Therapeutics Inc. performed very badly with a performance of -51.39%. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Heron Therapeutics Inc. | -50.938% | -50.938% | -78.209% |
| iShares Core DAX® | -1.756% | 1.667% | 2.099% |
| iShares Nasdaq 100 | 2.324% | 12.779% | 38.808% |
| iShares Nikkei 225® | 5.022% | 13.300% | 60.099% |
| iShares S&P 500 | 0.802% | 6.198% | 25.356% |
Comments by Rodman___Renshaw for this prediction
In the thread Heron Therapeutics Inc. diskutieren
Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat
In the thread Trading Heron Therapeutics Inc.
Die von Rodman___Renshaw gewählte maximale Laufzeit wurde überschritten